Mark Harrington

Changing WHO Global TB Program leadership

Statement from Mark Harrington, Executive Director of Treatment Action Group (TAG) on changing World Health Organization (WHO) Global TB Program leadership.

Read More →

Getting to zero – elements of a TB elimination campaign for leaders to endorse and implement

We need a new vision for TB writes AIDS and TB activist Mark Harrington, Executive Director of the Treatment Action Group.

Read More →

Time of great change in TB drug development

We are living in a time of great change and excitement in TB drug development. The last year has witnessed a number of epochal changes, including the approval and rollout of the most rapid test for TB ever discovered, the GeneXpert; the combination TB drug studies in the relapse mouse model of Eric Nuermberger and Jacques Grosset at Johns Hopkins with support from the TB Alliance; the progression of TMC207 into late phase II and of OPC67683 into phase III; and the first new regimen EBA study, NC-001 also from the Alliance.

Read More →

Page 1 of 1 · Total posts: 3